A class action lawsuit has been filed against Ardent Health Inc. in New York alleging securities fraud and other unlawful business practices by the company and certain executives and directors. The case follows Ardent’s November 2025 disclosure of a $43 million drop in third-quarter revenue tied to changes in its revenue accounting system, a cut to 2025 EBITDA guidance, and a $54 million increase in professional liability reserves, after which the stock fell about 34%. Investors seeking to be appointed lead plaintiff must file by March 9, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ardent Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603031315PRIMZONEFULLFEED9665069) on March 03, 2026, and is solely responsible for the information contained therein.